2013
DOI: 10.1016/j.atherosclerosis.2013.09.006
|View full text |Cite
|
Sign up to set email alerts
|

Cardiovascular risk in rheumatoid arthritis: How to lower the risk?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
40
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 56 publications
(40 citation statements)
references
References 139 publications
0
40
0
Order By: Relevance
“…Therefore, it has been proposed that autoimmune-mediated inflammation may contribute to increased CVD risk in RA. 20 RA-related autoantibody positivity has been associated with increased risk of CVD events among patients with RA. 2123 There is an increased prevalence of subclinical measures of atherosclerosis in RA, 24 and antibodies to modified citrullinated vimentin and anticyclic citrullinated peptide antibodies (anti-CCP) have been correlated with carotid intima media thickness (IMT) in early RA.…”
Section: Antiphospholipid Antibodies Rheumatoid Arthritis-related Aumentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, it has been proposed that autoimmune-mediated inflammation may contribute to increased CVD risk in RA. 20 RA-related autoantibody positivity has been associated with increased risk of CVD events among patients with RA. 2123 There is an increased prevalence of subclinical measures of atherosclerosis in RA, 24 and antibodies to modified citrullinated vimentin and anticyclic citrullinated peptide antibodies (anti-CCP) have been correlated with carotid intima media thickness (IMT) in early RA.…”
Section: Antiphospholipid Antibodies Rheumatoid Arthritis-related Aumentioning
confidence: 99%
“…Moreover, evidence is increasing for risk reduction from pharmaceutical interventions in active RA, such as anti–tumor necrosis factor α, hydroxychloroquine, statins, and possibly, methotrexate. 19,20 Because it has recently been shown that both rheumatologists and primary care physicians identify and manage cardiovascular risk factors less often in patients with RA compared with controls from the general population, interventions may be needed to improve CVD risk in patients with RA. 19,6062 Potential preventive interventions for CVD development in SLE are of course being proposed as well.…”
Section: Future Considerationsmentioning
confidence: 99%
“…It has been found that cardiovascular risks of NSAIDs are significantly different from each other. Generally, naproxen has been found less dangerous in consideration to the cardiovascular disease (CVD) in comparison to other NSAIDs [8]. The majority of NSAIDs comprise a carboxylic acid function, which admits direct carbodiimide combination of the drug to the pendent hydroxyl groups of dextran by the use of an ester bond.…”
Section: Symptomatic Treatmentmentioning
confidence: 99%
“…The precise mechanism of action through which NSAIDs boost the risk of a cardiovascular event is not completely known. According to suggestions the inhibiting of COX-II play considerable role in the mentioned risk profile of an individual NSAID [8].…”
Section: Symptomatic Treatmentmentioning
confidence: 99%
See 1 more Smart Citation